Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion

Journal of Cellular Biochemistry

Volumn 109, Issue 4, 2010, Pages 801-807

  Laparra, J M ^a   Sanz, Y ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Bifidobacterium; CACO 2; Celiac disease; Cytokines; Gliadin

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COMPLEMENTARY DNA; CYTOKINE; DNA; GLIADIN; GLUTEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PANCREATIN; PEPSIN A; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ARTICLE; BACTERIUM CULTURE; BIFIDOBACTERIUM; BILE; CELIAC DISEASE; CELL STRAIN CACO 2; CELL VIABILITY; CHRONIC DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTION; DNA CONTENT; ELECTROSPRAY MASS SPECTROMETRY; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

BIFIDOBACTERIUM; BIOLOGICAL MARKERS; BIOLOGICAL THERAPY; CACO-2 CELLS; CELIAC DISEASE; DIGESTION; EPITHELIAL CELLS; GLIADIN; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; PEPTIDE FRAGMENTS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM;

EID: 77749340870     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22459     Document Type: Article

References (30)

1. Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ. 1999. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur J Gastroenterol Hepatol 5:529-535.
2. Borenfreund E, Puerner J. 1985. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119-124.
3. Box GEP, Hunter NG, Hunter JS. 1978. Statistics for experimenters. An introduction to design, data analysis and model building. New York: John Wiley & Sons.
4. Chartrand LJ, Russo PA, Duhaine AG, Seidman EG. 1997. Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc 97:612-618.
5. Chiara M, DeStefano D, Mele G, Fecarotta S, Greco L, Troncone R, Carnuccio R. 2003. Nuclear factor kB is activated in small intestinal mucosa of celia patients. J Mol Med 81:373-379.
6. Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. 2007. Genes, diet and inflammatory bowel disease. Mutat Res 622:70-83.
7. Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M. 2000. Induction of apoptosis in Caco-2 cells by wheat gliadin peptides. Toxicology 145:63-71.
8. Giovannini C, Matarrese P, Scazzocchio B, Vari R, D'archivio M, Straface E, Masella R, Malorni W, De Vincenzi M. 2003. Wheat gliadin induced apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway. FEBS Lett 540:117-124.
9. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Göktuna SI, Neuenhahn M, Fierer J, Paxian S, Rooijen NV, Xu Y, O'Cain T, Jaffee BB, Busch DH, Duyster J, Schmid RM, Eckmann L, Karin M. 2007. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130:918-931.
10. Hoffman RA. 2000. Intraepithelial lymphocytes coinduce nitric oxide synthase in intestinal epithelial cells. Am J Physiol: Gastointest Liver Physiol 278:G886-G894.
11. Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-donohue T, Tamiz A, Alkan S, Netzel-Arnett S, Antalis T, Vogel SN, Fasano A. 2008. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135:194-204.
12. 2-induced oxidative stress in Caco-2 cells. Food Res Int 41:773-779.
13. Laparra JM, Glahn RP, Miller DD. 2009. Assessing potential effects of inulin and probiotic bacteria on Fe availability from common beans (Phaseolus vulgaris L.) to Caco-2 cells. J Food Sci 74:40-46.
14. Leeman JR, Gilmore TD. 2008. Alternative splicing in the NF-κB signaling pathway. Gene 423:97-107.
15. Lindfors K, Blomqvist T, Juuti-Uusitalo K, Stenman S, Venäläinen J, Mäki M, Kaukinen K. 2008. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol 152:552-558.
16. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. 2004. TNF-a-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation.AmJ Gastrointest Liver Physiol 286:G367-G376.
17. Medina M, De Palma G, Ribes-Koninckx C, Calabuig M, Sanz Y. 2008. Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J Inflamm (Lond) 5:19. 10.1186/1476-9255-5-19.
18. Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR. 1996. Increased small intestinal apoptosis in celiac disease. Gut 39:811-817.
19. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2007. Imbalance in the composition of the duodenal microbiota of children with celiac disease. J Med Microbiol 56:1669-1674.
20. Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P. 1998. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115:551-563.
21. Rojas A, Romay S, González D, Herrera B, Delgado R, Otero K. 2000. Regulation of endothelial nitric oxide synthase expression by albuminderived advanced glycosylation end products. Circ Res 86: E50-4.
22. Roselli M, Finamore A, Britti MS, Mengheri E. 2006. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 95:1177-1184.
23. Sanz Y. 2009. Novel perspectives in celiac disease therapy. Mini Rev Med Chem 9:359-367.
24. Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F. 2007. Differences in faeca bacterial communities in celiac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol 51:562-568.
25. Schmitz ML, Bacher S, Kracht M. 2001. IkB-independent control of NF-kB activity by modulatory phosphorylations. Trends Biochem Sci 26:186-190.
26. Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, Khosla C. 2005. Identification and analysis of multivalent proteolytically resistant peptides from gluten: Implications for celiac sprue. J Proteome Res 4:1732-1741.
27. Thomas KE, Sapone A, Fasano A, Vogel SN. 2006. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: Role of the innate immune response in celiac disease. J Immunol 176:2512-2521.
28. Troncone R, Ivarsson A, Szajewska H, Mearins ML. 2008. Review article: Future research on coeliac disease-A position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther 27:1030-1043.
29. Wieser H, Koehler P. 2008. The biochemical basis of celiac disease. Cereal Chem 85:1-13.
30. Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K, Lane JM, Fitzharris P, Crane J, Town I, Addo-Yobo E, Murray CS, Woodcock A. 2004. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 11:686-690.